|
|
General
|
| |
Clinical Use:
|
Valganciclovir is a pro-drug that delivers ganciclovir with greater bioavailability. Ganciclovir is monitored. Valganciclovir is use for treatment of Cytomegalovirus in immuno-compromised patients including transplant recipients and AIDS patients. |
| |
Availability:
|
|
| |
Aliases/Synonyms:
| Valganciclovir, |
| |
Code:
|
GAN |
| |
Handling Instructions (to laboratory):
|
Send sample chilled. |
| |
Hyperlink:
|
|
| |
Reference Interval:
|
No reference range established
|
Collection Requirements
|
| |
Container:
|
Serum, no gel (RED), |
| |
Sample Type:
|
See container |
| |
Minimum Collection Volume:
|
|
| |
Collection Instructions:
|
Refer to Duty Biochemist prior to collection of sample. |
Processing Requirements
|
| |
Alternate Containers:
|
|
|
|
|
Lithium Heparin, No Gel (DKGNLITH) |
| |
Processing Instructions:
|
Centrifuge, separate and refrigerate sample. |
| |
Minimum Assay Volume:
|
0.5mL |
| |
Stability:
|
|
| |
Transport Instructions (to testing laboratory):
|
Send sample chilled. |
Testing Locations
|
| |
Performed at:
|
|
Section
|
Department
|
Site
|
Contact Phone
|
| Toxicology |
Clinical Pharmacology |
QEII Medical Centre |
6383 4126 |
|
Last Updated : 01-02-2023 11:48 |